BUNGE GLOBAL SA (BG)

CH1300646267 - Common Stock

110.055  +3.55 (+3.33%)

Fundamental Rating

6

Taking everything into account, BG scores 6 out of 10 in our fundamental rating. BG was compared to 91 industry peers in the Food Products industry. Both the health and profitability get an excellent rating, making BG a very profitable company, without any liquidiy or solvency issues. BG is valued quite cheap, but it does not seem to be growing. With these ratings, BG could be worth investigating further for value investing!.



7

1. Profitability

1.1 Basic Checks

In the past year BG was profitable.
In the past year BG had a positive cash flow from operations.
Of the past 5 years BG 4 years were profitable.
BG had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

The Return On Assets of BG (8.84%) is better than 89.01% of its industry peers.
Looking at the Return On Equity, with a value of 20.67%, BG belongs to the top of the industry, outperforming 92.31% of the companies in the same industry.
With an excellent Return On Invested Capital value of 13.58%, BG belongs to the best of the industry, outperforming 94.51% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for BG is significantly above the industry average of 7.56%.
The last Return On Invested Capital (13.58%) for BG is above the 3 year average (12.86%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 8.84%
ROE 20.67%
ROIC 13.58%
ROA(3y)7.99%
ROA(5y)4.3%
ROE(3y)21.59%
ROE(5y)12.18%
ROIC(3y)12.86%
ROIC(5y)10.32%

1.3 Margins

With a decent Profit Margin value of 3.77%, BG is doing good in the industry, outperforming 64.84% of the companies in the same industry.
BG's Profit Margin has improved in the last couple of years.
The Operating Margin of BG (5.34%) is better than 65.93% of its industry peers.
In the last couple of years the Operating Margin of BG has grown nicely.
Looking at the Gross Margin, with a value of 8.15%, BG is doing worse than 68.13% of the companies in the same industry.
BG's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 5.34%
PM (TTM) 3.77%
GM 8.15%
OM growth 3Y17.85%
OM growth 5Y25.08%
PM growth 3Y11.64%
PM growth 5Y49.21%
GM growth 3Y6.61%
GM growth 5Y10.47%

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BG is still creating some value.
BG has more shares outstanding than it did 1 year ago.
BG has more shares outstanding than it did 5 years ago.
The debt/assets ratio for BG is higher compared to a year ago.

2.2 Solvency

An Altman-Z score of 4.47 indicates that BG is not in any danger for bankruptcy at the moment.
The Altman-Z score of BG (4.47) is better than 83.52% of its industry peers.
The Debt to FCF ratio of BG is 2.23, which is a good value as it means it would take BG, 2.23 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of BG (2.23) is better than 83.52% of its industry peers.
A Debt/Equity ratio of 0.45 indicates that BG is not too dependend on debt financing.
BG has a Debt to Equity ratio (0.45) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 2.23
Altman-Z 4.47
ROIC/WACC1.5
WACC9.03%

2.3 Liquidity

A Current Ratio of 2.13 indicates that BG has no problem at all paying its short term obligations.
With a decent Current ratio value of 2.13, BG is doing good in the industry, outperforming 69.23% of the companies in the same industry.
BG has a Quick Ratio of 1.20. This is a normal value and indicates that BG is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of BG (1.20) is better than 73.63% of its industry peers.
Industry RankSector Rank
Current Ratio 2.13
Quick Ratio 1.2

3

3. Growth

3.1 Past

The earnings per share for BG have decreased by -1.80% in the last year.
BG shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 55.43% yearly.
The Revenue for BG has decreased by -11.44% in the past year. This is quite bad
Measured over the past years, BG shows a small growth in Revenue. The Revenue has been growing by 5.41% on average per year.
EPS 1Y (TTM)-1.8%
EPS 3Y25.7%
EPS 5Y55.43%
EPS growth Q2Q14.2%
Revenue 1Y (TTM)-11.44%
Revenue growth 3Y12.87%
Revenue growth 5Y5.41%
Revenue growth Q2Q-10.35%

3.2 Future

The Earnings Per Share is expected to decrease by -6.74% on average over the next years.
The Revenue is expected to grow by 0.33% on average over the next years.
EPS Next Y-26.02%
EPS Next 2Y-12.44%
EPS Next 3Y-6.74%
EPS Next 5YN/A
Revenue Next Year-5.72%
Revenue Next 2Y-2.24%
Revenue Next 3Y0.33%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

7

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 8.05, the valuation of BG can be described as very reasonable.
Based on the Price/Earnings ratio, BG is valued cheaper than 97.80% of the companies in the same industry.
BG is valuated cheaply when we compare the Price/Earnings ratio to 24.80, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 11.30, which indicates a very decent valuation of BG.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BG indicates a rather cheap valuation: BG is cheaper than 90.11% of the companies listed in the same industry.
BG is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 21.27, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 8.05
Fwd PE 11.3

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BG indicates a rather cheap valuation: BG is cheaper than 93.41% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, BG is valued cheaper than 87.91% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.22
EV/EBITDA 4.22

4.3 Compensation for Growth

The decent profitability rating of BG may justify a higher PE ratio.
A cheap valuation may be justified as BG's earnings are expected to decrease with -6.74% in the coming years.
PEG (NY)N/A
PEG (5Y)0.15
EPS Next 2Y-12.44%
EPS Next 3Y-6.74%

6

5. Dividend

5.1 Amount

BG has a Yearly Dividend Yield of 2.50%.
Compared to an average industry Dividend Yield of 3.56, BG pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.40, BG has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.5%

5.2 History

The dividend of BG has a limited annual growth rate of 4.77%.
BG has been paying a dividend for at least 10 years, so it has a reliable track record.
BG has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)4.77%
Div Incr Years3
Div Non Decr Years19

5.3 Sustainability

BG pays out 17.08% of its income as dividend. This is a sustainable payout ratio.
DP17.08%
EPS Next 2Y-12.44%
EPS Next 3Y-6.74%

BUNGE GLOBAL SA

NYSE:BG (4/19/2024, 2:34:02 PM)

110.055

+3.55 (+3.33%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap15.78B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 2.5%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 8.05
Fwd PE 11.3
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)0.15
Profitability
Industry RankSector Rank
ROA 8.84%
ROE 20.67%
ROCE
ROIC
ROICexc
ROICexgc
OM 5.34%
PM (TTM) 3.77%
GM 8.15%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover2.35
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.13
Quick Ratio 1.2
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-1.8%
EPS 3Y25.7%
EPS 5Y
EPS growth Q2Q
EPS Next Y-26.02%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-11.44%
Revenue growth 3Y12.87%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y